Cadrenal Therapeutics, Inc. (CVKD)
8.49
+0.11
(+1.31%)
USD |
NASDAQ |
Feb 27, 16:00
8.56
+0.07
(+0.82%)
After-Hours: 20:00
Cadrenal Therapeutics EPS Diluted (Quarterly) : -1.314 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PTC Therapeutics, Inc. | -1.673 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.686M |
| Total Expenses (Quarterly) | 2.686M |
| Enterprise Value | 15.99M |
| Earnings Yield | -94.40% |
| Normalized Earnings Yield | -94.40 |